Old Web
English
Sign In
Acemap
>
authorDetail
>
Ma Teresa Aznar Saliente
Ma Teresa Aznar Saliente
Medicine
Adverse effect
Survival rate
Toxicity
Atezolizumab
3
Papers
8
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Clinical efficacy and safety of anti PD-1/PD-L1 antibodies as monotherapy in patients with non-small-cell lung cancer.
2020
Farmacia Hospitalaria
Marta Zayas Soriano
Manuel Bonete Sanchez
Juan Campillo López
Borja Marcos Ribes
Ana Hernández Guio
Ma Teresa Aznar Saliente
Show All
Source
Cite
Save
Citations (0)
Efectividad y seguridad en la práctica clínica de anticuerpos anti PD-1/PD-L1 en monoterapia en el cáncer de pulmón no microcítico
2020
Farmacia Hospitalaria
Marta Zayas Soriano
Manuel Bonete Sanchez
Juan Campillo López
Borja Marcos Ribes
Ana Hernández Guio
Ma Teresa Aznar Saliente
Show All
Source
Cite
Save
Citations (0)
Drug‐related problems at discharge: results on the Spanish pharmacy discharge programme CONSULTENOS
2010
International Journal of Pharmacy Practice
MaÁngeles Pardo López
Ma Teresa Aznar Saliente
Ana García Monsalve
Marta Aparício Cueva
Elena Arroyo Domingo
Mónica Montero Hernández
Carmen Carrión Carrión
Mónica Climente Martí
Nuria Bujaldón Querejeta
Joaquín Borrás Blasco
Amparo Rocher Milá
Show All
Source
Cite
Save
Citations (8)
1